20 January – Monday

08:30 Registration
08:45 Opening Remarks and Welcome Address
09:00 HONORARY LECTURE
09:20 EXPERT PANEL DISCUSSION: Early Stage HepatoCellularCarcinoma
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION

  • Early Stage Cases from MIOLive 2019: Were the experts right? What have we learned?
  • Presentation of new cases
11:00 Coffee Break
11:15 LIVE CASES
11:30 SESSION: IO & Advanced Imaging

  • Augmented Reality
  • Robotics
  • Fusion Imging
  • Discussion
12:30 “Primum Non Nocere”: Ablation
13:00 LUNCH SYMPOSIUM: MIOLive meets CIRSE
14:00 HONORARY LECTURE
14:15 LIVE CASES
14:45 SESSION: Interventional MSK procedures: Extraspinal lesions

  • Radiotherapy
  • IO & Curative options
  • Consolidation
  • Embolization
  • Discussion
16:00 LIVE CASES
16:30 Coffee Break
16:45 EXPERT PANEL DISCUSSION: Intermediate HepatoCellularCarcinoma
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION

  • Intermediate Stage Cases from MIOLive 2019: Were the experts right? What have we learned?
  • Presentation of new cases
18:30 Plenary Discussion on patients treated

 

21 January – Tuesday

08:30 IO in the era of Bio-informatics: Large database and predictive models
09:30 THERANOSTICS IN INTERVENTIONAL ONCOLOGY: where are we going?
09:45 LIVE CASES
10:15 “Primum Non Nocere”: Chemoembolization
10:30 Coffee Break
10:45 LIVE CASES
11:15 EXPERT PANEL DISCUSSION: Advanced HepatoCellularCarcinoma
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION

  • Advanced Stage Cases from MIOLive 2019: Were the experts right? What have we learned?
  • Presentation of new cases
12:45 LIVE CASES
13:15 LUNCH & LEARN Session: Industry Symposium
14:10 LIVE CASES
14:30 5-YEAR RESULTS FROM MIOLIVE 2015: WERE THE EXPERTS RIGHT? WHAT’S CHANGED?
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION
15:30 LIVE CASES
15:30 5-YEAR RESULTS FROM MIOLIVE 2015: WERE THE EXPERTS RIGHT? WHAT’S CHANGED?/strong>
16:15 ABSTRACT SESSION: BE INNOVATIVE, SHARE YOUR EXPERIENCE
(registered live cases showing new techniques and new devices for intra-arterial and percutaneous liver procedures)
17:30 LIVE CASES
18:00 Plenary Discussion on patients treated
18:15 End